Pancreatic Cancer Research

ResearcherUniversità Cattolica del Sacro CuoreNo recent work listed

Vincenzo Valentini

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4637-6487; OpenAlex author ID A5008208200. Sources: OpenAlex.

Their work

Papers
22 (first author 0, last author 9)
Trials
0
Grants
0
Labs led
2
Collaborators
60
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 5 papers · 2020: 3 papers · 2021: 4 papers · 2022: 3 papers

Papers 22

  1. Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis. Last author DOI 10.1159/000525945↗
  2. The impact of radiomics in diagnosis and staging of pancreatic cancer. Co-author DOI 10.1177/26317745221081596↗
  3. Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm? Co-author DOI 10.3390/life12040465↗
  4. Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients. Last author DOI 10.1007/s00432-020-03411-7↗
  5. Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients. Last author DOI 10.1007/s00432-020-03439-9↗
  6. ESTRO ACROP guidelines for target volume definition in pancreatic cancer. Co-author DOI 10.1016/j.radonc.2020.07.052↗
  7. Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy. Last author DOI 10.3390/diagnostics11010072↗
  8. Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer. Co-author DOI 10.1002/acm2.13025↗
  9. On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. Last author DOI 10.1016/j.tipsro.2020.06.001↗
  10. Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical … Co-author DOI 10.3390/cancers12071729↗
  11. Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer. Co-author DOI 10.1002/acm2.12697↗
  12. Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. Last author DOI 10.1016/j.tranon.2018.08.017↗
  13. Magnetic resonance imaging (MRI) compared with computed tomography (CT) for interobserver agreement of gross tumor volume delineation in pancreatic cancer: a m… Co-author DOI 10.1080/0284186x.2018.1546899↗
  14. Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. Co-author DOI 10.1186/s12885-019-5790-2↗
  15. Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls. Last author DOI 10.1186/s13014-019-1275-3↗
  16. Multimodal treatment of resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.critrevonc.2017.01.015↗
  17. Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.critrevonc.2015.11.016↗
  18. Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey. Co-author DOI 10.3892/or.2015.3955↗
  19. Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. Co-author PMID 26026108↗
  20. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer. Last author DOI 10.1016/j.ijrobp.2014.07.024↗
  21. Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma. Last author DOI 10.1245/s10434-012-2767-7↗
  22. Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer. Co-author DOI 10.1186/1748-717x-7-86↗

Closest collaborators

The 25 strongest of 60 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Francesco Cellini · 14 shared papers, 2016–2022 · strength 1.37
  2. Gian Carlo Mattiucci · 15 shared papers, 2013–2022 · strength 1.28
  3. Alessio Giuseppe Morganti · 16 shared papers, 2012–2022 · strength 1.17
  4. Luca Boldrini · 7 shared papers, 2019–2022 · strength 0.80
  5. Gabriella Macchia · 10 shared papers, 2012–2022 · strength 0.77
  6. Milly Buwenge · 6 shared papers, 2019–2021 · strength 0.58
  7. Davide Cusumano · 5 shared papers, 2019–2022 · strength 0.56
  8. Sergio Alfieri · 6 shared papers, 2013–2022 · strength 0.37
  9. Nicola Simoni · 3 shared papers, 2019–2022 · strength 0.32
  10. Massimo Falconi · 6 shared papers, 2014–2019 · strength 0.31
  11. Michele Reni · 6 shared papers, 2014–2019 · strength 0.31
  12. Lorenzo Placidi · 3 shared papers, 2019–2021 · strength 0.31
  13. Renzo Mazzarotto · 2 shared papers, 2020–2022 · strength 0.25
  14. Domenico Genovesi · 4 shared papers, 2015–2020 · strength 0.24
  15. Maria Antonietta Gambacorta · 2 shared papers, 2021–2022 · strength 0.24
  16. Calogero Casà · 2 shared papers, 2021–2022 · strength 0.24
  17. Alessandra Arcelli · 3 shared papers, 2019–2020 · strength 0.23
  18. Luciana Caravatta · 4 shared papers, 2012–2020 · strength 0.23
  19. Stefano Partelli · 4 shared papers, 2015–2019 · strength 0.21
  20. William F. Regine · 4 shared papers, 2014–2019 · strength 0.21
  21. Felipe Ángel Calvo Manuel · 4 shared papers, 2014–2019 · strength 0.21
  22. Robert Clell Miller · 4 shared papers, 2014–2019 · strength 0.21
  23. Joseph M. Herman · 4 shared papers, 2014–2019 · strength 0.21
  24. Oronzo Brunetti · 3 shared papers, 2016–2020 · strength 0.20
  25. Nicola Silvestris · 3 shared papers, 2016–2020 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.